CIN: U46497TN2026PTC189302  |  22 Years of Pharmaceutical Legacy  |  Madurai, Tamil Nadu, India

+91 70103 81704
  • Quality
    Quality Standards

    High standards across our portfolio

  • Integrity
    Ethical Integrity

    Professional & transparent marketing

  • Commitment
    Healthcare Focus

    Patient wellbeing at the centre

  • Reliability
    Reliability & Trust

    22 years of trusted partnerships

Dr. Santhosh Lenin Bangaru
Our Journey

22 Years of Pharmaceutical Experience

  • icon
    22 Years of Experience

    Built on more than two decades of dedicated service, relationships and clinical healthcare commitment.

  • icon
    Established Legacy

    Preserving the enduring vision, values and dedication established by late founder Mr. Bangaru Muthu Venkatachalapathy.

  • icon
    New Corporate Chapter & Future Growth

    Incorporated in 2026 as DCC Pharmaceuticals Private Limited, expanding healthcare access nationwide.

Read Our Legacy
Flagship Portfolio

Essential Healthcare Formulations

DC-VILDA
10 x 10 Tabs
Anti-Diabetic
DC-VILDA
Vildagliptin 50 mg
Inquire Now DCC Pharma
DC-SITA M
10 x 10 Tabs
Anti-Diabetic
DC-SITA M
Sitagliptin 50 mg + Metformin 500 mg
Inquire Now DCC Pharma
DC-AZEE 500
10 x 3 Tabs
Oral Antibiotics
DC-AZEE 500
Azithromycin 500 mg
Inquire Now DCC Pharma
D-STAT 20
10 x 10 Tabs
Statins
D-STAT 20
Atorvastatin 20 mg
Inquire Now DCC Pharma
Standards

Quality &
Compliance

Explore
Our Motto Beyond Cures

Patient-Centric
Solutions

Our Vision
Pan-India

Dependable
Partnerships

Partner With Us
quote
quote
Partnerships & Trust

Healthcare Professional Endorsements

Clinical Insights

Latest Pharmaceutical Updates

Diabetes Management

Advanced Glycemic Control in Type 2 Diabetes Care

Examining modern DPP-4 inhibitors and combination therapies for enhanced glycemic stability and metabolic protection...

Antibiotic Stewardship

Rational Use of Broad-Spectrum Oral Antibiotics

Key clinical principles in selecting oral antibiotics to optimize pathogen clearance while minimizing resistance...

Cardiovascular Prevention

Cardiovascular Risk Reduction with Targeted Statins

Understanding high-intensity lipid-lowering therapies and anti-anginal formulations for long-term myocardial care...